Related Experiment Video

Updated: Jul 15, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.0K

Letter: NSBB for fatty liver disease-Still a long way to go. Authors' reply

Mathias Jachs1,2, Rafael Paternostro1,2, Thomas Reiberger1,2,3

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Alimentary Pharmacology & Therapeutics
|September 28, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

935
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.0K

Related Experiment Videos

Last Updated: Jul 15, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.0K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

935
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.0K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

135
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
135
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

614
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
614
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

108
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
108

Articles linked to this work by shared authors, journal, and citation graph.

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.

Liver international : official journal of the International Association for the Study of the Liver·2026

Course of Portal Hypertension and Its Prognostic Impact After Liver Transplantation.

United European gastroenterology journal·2026

Histomorphometry indicates distinct contributions of myofibroblast activation and sinusoidal capillarization to portal hypertension.

Hepatology international·2026

Changes in SSM Assessed via 100 Hz-VCTE Are Associated With Acute HVPG-Response to i.v. Propranolol: A European Multicentre Study.

Liver international : official journal of the International Association for the Study of the Liver·2026

Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension.

Scientific reports·2026

Evolution of liver disease severity and portal hypertension during REP 2139-Mg treatment in 3 patients with chronic hepatitis D : Case reports.

Wiener klinische Wochenschrift·2026

Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.

Alimentary pharmacology & therapeutics·2026

HLA-A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection.

Alimentary pharmacology & therapeutics·2026

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Alimentary pharmacology & therapeutics·2026

Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer.

Alimentary pharmacology & therapeutics·2026

Pharmacokinetic and Pharmacodynamic Variability Predict Late Events After Paediatric Liver Transplantation: Derivation and External Validation of a Landmark Risk Score.

Alimentary pharmacology & therapeutics·2026

Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index.

Alimentary pharmacology & therapeutics·2026

Hemicerebral atrophy as an unusual central nervous system manifestation of Neurofibromatosis type 1: A case report.

Radiology case reports·2026

"Ears of the lynx" sign on MRI: A radiologic clue to hereditary spastic paraplegia.

Radiology case reports·2026

Retinal manifestations of neglected tropical diseases.

Current opinion in ophthalmology·2026

Towards a domain-general mechanistic model of fatigue: application to Functional Neurological Disorder.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026

Investigating mechanisms and monitoring outcomes in functional neurological disorder: the unrealized potential of digital remote monitoring technologies.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026

Neurofeedback for functional neurological disorders: future directions for research and clinical practice.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us